Acute kidney injury after ingestion of rhubarb: Secondary oxalate nephropathy in a patient with type 1 diabetes

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Albersmeyer, Marc ^a   Hilge, Robert ^a   Schröttle, Angelika ^a   Weiss, Max ^a   Sitter, Thomas ^a   Vielhauer, Volker ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diabetes; Hyperoxaluria; Malabsorption; Oxalate; Renal failure; Rhubarb

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; AUTOANTIBODY; CALCIUM; CREATININE; INSULIN; INSULIN GLARGINE; METOPROLOL; OXALIC ACID; RAMIPRIL; UREA;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPOGLYCEMIA; INGESTION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; LABORATORY TEST; MESANGIAL SCLEROSIS; MICROALBUMINURIA; NAUSEA AND VOMITING; OXALOSIS; RENOGRAPHY; RHUBARB; SCLEROSIS; SECONDARY OXALATE NEPHROPATHY; URINALYSIS;

ACUTE KIDNEY INJURY; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MIDDLE AGED; OXALATES; RHEUM;

EID: 84867897463     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-141     Document Type: Article

References (22)

1. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type III. Hoppe B, Nephrol Dial Transplant 2012 27 3024 3026 10.1093/ndt/gfs308 22851625
2. An update on primary hyperoxaluria. Hoppe B, Nat Rev Nephrol 2012 8 467 475 10.1038/nrneph.2012.113 22688746
3. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. Siva S, Barrack ER, Reddy GPV, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M, BJU Int 2009 103 18 21 10.1111/j.1464-410X.2008.08122.x 19021605
4. Hyperoxaluria and systemic oxalosis: current therapy and future directions. Bobrowski AE, Langman CB, Expert Opin Pharmacother 2006 7 1887 1896 10.1517/14656566.7.14.1887 17020415 (Pubitemid 44489363)
5. Vitamin C-induced oxalate nephropathy. Lamarche J, Nair R, Peguero A, Courville C, Int J Nephrol 2011 2011 146927 21603151
6. Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis. Rodman JS, Mahler RJ, Urol Clin North Am 2000 27 275 285 viii 10.1016/S0094-0143(05)70257-3 10778470 (Pubitemid 30196796)
7. Oxalate content of foods and its effect on humans. Noonan S, Asia Pacific J Clin Nutr 1999 8 64 74 10.1046/j.1440-6047.1999.00038.x
8. Comparison of oxalate content in foods and beverages in Taiwan. Tsai J-J, Huang CW, Wu J-K, Tony T, Lee Y, J Taiwan Urol Assoc 2005 16 93 99
9. Herbal treatment for renal diseases. Peng A, Gu Y, Lin SY, Ann Acad Med Singap 2005 34 44 51 15726219 (Pubitemid 40379972)
10. Oxalate nephropathy associated with chronic pancreatitis. Cartery C, Faguer S, Karras A, Cointault O, Buscail L, Modesto A, Ribes D, Rostaing L, Chauveau D, Giraud P, Clin J Am Soc Nephrol 2011 6 1895 1902 10.2215/CJN.00010111 21737848
11. Oxalate nephropathy in a diabetic patient after gastric by-pass. Moutzouris D-A, Skaneli G, Margellos V, Apostolou T, Petraki C, Nikolopoulou N, Clin Nephrol 2011 75 Suppl 1 16 19 21269587
12. Acute oxalate nephropathy: a new etiology for acute renal failure following nonrenal solid organ transplantation. Lefaucheur C, Hill GS, Amrein C, Haymann JP, Jacquot C, Glotz D, Nochy D, Am J Transplant 2006 6 2516 2521 10.1111/j.1600-6143.2006.01485.x 16889602 (Pubitemid 44359445)
13. Acute oxalate nephropathy after ingestion of star fruit. Chen CL, Fang HC, Chou KJ, Wang JS, Chung HM, Am J Kidney Dis 2001 37 418 422 10.1053/ajkd.2001.21333 11157385
14. Oxalate nephropathy with a granulomatous lesion due to excessive intake of peanuts. Sasaki M, Murakami M, Matsuo K, Matsuo Y, Tanaka S, Ono T, Mori N, Clin Exp Nephrol 2008 12 305 308 10.1007/s10157-008-0046-5 18335167
15. Clinical and pathological findings in fatal plant oxalosis. A review. Sanz P, Reig R, Am J Forensic Med Pathol 1992 13 342 345 10.1097/00000433- 199212000-00016 1288268
16. Dietary oxalate loads and renal oxalate handling. Holmes RP, Ambrosius WT, Assimos DG, J Urol 2005 174 943 947 10.1097/01.ju.0000169476.85935.e2 16094002 (Pubitemid 41140641)
17. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria. Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F, Nephrol Dial Transplant 1993 8 1333 1337 8159301 (Pubitemid 24038067)
18. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H, Kidney Int 2006 70 1305 1311 10.1038/sj.ki.5001707 16850020 (Pubitemid 44435182)
19. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Lieske JC, Tremaine WJ, De Simone C, OConnor HM, Li X, Bergstralh EJ, Goldfarb DS, Kidney Int 2010 78 1178 1185 10.1038/ki.2010.310 20736987
20. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Illies F, Bonzel K-E, Wingen A-M, Latta K, Hoyer PF, Kidney Int 2006 70 1642 1648 10.1038/sj.ki.5001806 16955107 (Pubitemid 44607001)
21. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB, Am J Kidney Dis 2011 58 453 455 10.1053/j.ajkd.2011.05.012 21705122
22. Probiotics and dietary manipulations in calcium oxalate nephrolithiasis: two sides of the same coin? Borghi L, Nouvenne A, Meschi T, Kidney Int 2010 78 1063 1065 10.1038/ki.2010.345 21076446